Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Xspray Pharma reports positive results from HyNap-Dasa Phase I study

This photo shows non-small cell lung cancer in a 54-year-old woman. Credit: Oregon State University.



Go Top